Novo Nordisk A S (NVO)

Sector:Health Care
Super Investor Stats:
Ownership count:4
Ownership rank:127
% of all portfolios:0.065%
Hold Price * :$119.07
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
Lee Ainslie - Maverick Capital Sell 100.00% 7,849 0.02
Polen Capital Management Reduce 7.97% 593,313 0.18
Q2  2024
Polen Capital Management Reduce 4.13% 320,807 0.12
Q1  2024
Polen Capital Management Reduce 2.38% 189,665 0.06
Q2  2023
Lee Ainslie - Maverick Capital Sell 100.00% 4,312 0.01
Q1  2023
Lee Ainslie - Maverick Capital Reduce 6.42% 296 0.00
Q4  2022
Lee Ainslie - Maverick Capital Reduce 6.91% 342 0.00
Q1  2021
Lee Ainslie - Maverick Capital Sell 100.00% 5,316 0.00
Q4  2020
Lee Ainslie - Maverick Capital Reduce 70.25% 12,550 0.00
Q1  2020
Polen Capital Management Sell 100.00% 237,618 0.03
Q1  2014
Thomas Gayner - Markel Group Reduce 2.80% 62,000 0.04
Q4  2013
Thomas Gayner - Markel Group Reduce 0.23% 5,000 0.00
Q3  2013
Thomas Gayner - Markel Group Reduce 1.51% 34,000 0.02
Q2  2013
Thomas Gayner - Markel Group Reduce 0.57% 13,000 0.01
Q1  2013
Thomas Gayner - Markel Group Reduce 0.40% 9,000 0.01
Q4  2012
Thomas Gayner - Markel Group Reduce 0.35% 8,000 0.01
Q3  2012
Thomas Gayner - Markel Group Reduce 0.35% 8,000 0.01
Q1  2012
Thomas Gayner - Markel Group Reduce 0.96% 22,000 0.01
Q4  2011
Thomas Gayner - Markel Group Reduce 0.11% 2,500 0.00
Q2  2011
Thomas Gayner - Markel Group Reduce 0.09% 2,000 0.00
Q1  2011
Thomas Gayner - Markel Group Reduce 0.43% 10,000 0.01
Q4  2010
Thomas Gayner - Markel Group Reduce 0.09% 2,000 0.00
Q3  2010
Thomas Gayner - Markel Group Reduce 0.28% 6,500 0.00

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.